People · Operator
Named in public records as an officer, director or promoter · active 2020–2023 · Biotech, Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Watchmaker Genomics, Inc. | — | Biotech | Series B | $48.3M | $712.8M | 2020 |
| LTS1, Inc. | — | Other | Series A | $10.0M | $14.2M | 2021 |
| Molecular Loop Biosciences, Inc. | — | Biotechnology | Seed | $3.3M | $34.0M | 2022 |
Christopher McGuinness at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christopher McGuinness on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Paul McEwan | 2 | 3 |
| William Snider | 1 | 7 |
| Victor Tong | 1 | 6 |
| David Mullarkey | 1 | 2 |
| Stephen Picone | 1 | 2 |
| Gregory Porreca | 1 | 1 |
| Christopher McGuiness | 1 | 1 |
| Christopher Boggess | 1 | 1 |
| Brian Kudlow | 1 | 1 |
| Brian Deneau | 1 | 1 |
| John Foskett | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.